Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 2
1978 1
1979 1
1980 1
1981 4
1982 2
1983 3
1984 3
1985 4
1986 7
1987 4
1988 6
1989 10
1990 8
1991 11
1992 9
1993 5
1994 12
1995 6
1996 10
1997 11
1998 9
1999 11
2000 11
2001 8
2002 8
2003 10
2004 8
2005 13
2006 6
2007 20
2008 14
2009 20
2010 19
2011 12
2012 7
2013 7
2014 6
2015 4
2016 5
2017 4
2018 7
2019 6
2020 4
2021 4
2022 2
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Results by year

Filters applied: . Clear all
Page 1
Bleomycin.
Lazo JS. Lazo JS. Cancer Chemother Biol Response Modif. 1999;18:39-45. Cancer Chemother Biol Response Modif. 1999. PMID: 10800476 Review. No abstract available.
Drugging Undruggable Molecular Cancer Targets.
Lazo JS, Sharlow ER. Lazo JS, et al. Annu Rev Pharmacol Toxicol. 2016;56:23-40. doi: 10.1146/annurev-pharmtox-010715-103440. Epub 2015 Nov 2. Annu Rev Pharmacol Toxicol. 2016. PMID: 26527069 Review.
Refining Radiation for the Next Century.
Lazo JS. Lazo JS. Mol Cancer Ther. 2018 Feb;17(2):332-335. doi: 10.1158/1535-7163.MCT-17-1244. Mol Cancer Ther. 2018. PMID: 29420296 No abstract available.
Bleomycin.
Lazo JS, Sebti SM. Lazo JS, et al. Cancer Chemother Biol Response Modif. 1997;17:40-5. Cancer Chemother Biol Response Modif. 1997. PMID: 9551207 Review. No abstract available.
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells.
Chokshi CR, Shaikh MV, Brakel B, Rossotti MA, Tieu D, Maich W, Anand A, Chafe SC, Zhai K, Suk Y, Kieliszek AM, Miletic P, Mikolajewicz N, Chen D, McNicol JD, Chan K, Tong AHY, Kuhlmann L, Liu L, Alizada Z, Mobilio D, Tatari N, Savage N, Aghaei N, Grewal S, Puri A, Subapanditha M, McKenna D, Ignatchenko V, Salamoun JM, Kwiecien JM, Wipf P, Sharlow ER, Provias JP, Lu JQ, Lazo JS, Kislinger T, Lu Y, Brown KR, Venugopal C, Henry KA, Moffat J, Singh SK. Chokshi CR, et al. Among authors: lazo js. Nat Med. 2024 Aug 2. doi: 10.1038/s41591-024-03138-9. Online ahead of print. Nat Med. 2024. PMID: 39095594
Small molecule targeting of PTPs in cancer.
Lazo JS, McQueeney KE, Burnett JC, Wipf P, Sharlow ER. Lazo JS, et al. Int J Biochem Cell Biol. 2018 Mar;96:171-181. doi: 10.1016/j.biocel.2017.09.011. Epub 2017 Sep 21. Int J Biochem Cell Biol. 2018. PMID: 28943273 Review.
Drug discovery algorithm for cutaneous leishmaniasis.
Grogl M, Hickman M, Ellis W, Hudson T, Lazo JS, Sharlow ER, Johnson J, Berman J, Sciotti RJ. Grogl M, et al. Among authors: lazo js. Am J Trop Med Hyg. 2013 Feb;88(2):216-21. doi: 10.4269/ajtmh.11-0812. Am J Trop Med Hyg. 2013. PMID: 23390221 Free PMC article. Review.
Role of metallothionein in carcinogenesis.
Cherian MG, Howell SB, Imura N, Klaassen CD, Koropatnick J, Lazo JS, Waalkes MP. Cherian MG, et al. Among authors: lazo js. Toxicol Appl Pharmacol. 1994 May;126(1):1-5. doi: 10.1006/taap.1994.1083. Toxicol Appl Pharmacol. 1994. PMID: 8184419 Review.
334 results